ALPEK. de Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de ALPEK. de han disminuido a una tasa media anual de -36.8%, mientras que en la industria Chemicals los beneficios crecieron en un 10.7% anualmente. Los ingresos han ido creciendo a una tasa media de 6.4% al año.

Información clave

-36.8%

Tasa de crecimiento de los beneficios

-36.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	13.1%
Tasa de crecimiento de los ingresos	6.4%
Rentabilidad financiera	-26.8%
Margen neto	-7.6%
Última actualización de beneficios	30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

ALPEK, S.A.B. de C.V. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 27

A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)

Jun 21

Some Investors May Be Worried About ALPEK. de's (BMV:ALPEKA) Returns On Capital

Jun 06

Earnings Miss: ALPEK, S.A.B. de C.V. Missed EPS By 51% And Analysts Are Revising Their Forecasts

Apr 25

What ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) P/S Is Not Telling You

Apr 13

At Mex$12.61, Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Worth Looking At Closely?

Mar 26

ALPEK. de (BMV:ALPEKA) Has A Somewhat Strained Balance Sheet

Mar 08

A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)

Jan 22

Investor Optimism Abounds ALPEK, S.A.B. de C.V. (BMV:ALPEKA) But Growth Is Lacking

Jan 04

Is There Now An Opportunity In ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Dec 14

ALPEK. de (BMV:ALPEKA) Use Of Debt Could Be Considered Risky

Nov 24

Is Now The Time To Look At Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Sep 02

ALPEK. de (BMV:ALPEKA) Has A Somewhat Strained Balance Sheet

Jul 16

ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Intrinsic Value Is Potentially 91% Above Its Share Price

Jun 27

The ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Analysts Have Been Trimming Their Sales Forecasts

Apr 30

When Should You Buy ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Apr 20

An Intrinsic Calculation For ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Suggests It's 34% Undervalued

Mar 28

These Analysts Think ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Sales Are Under Threat

Feb 25

Is ALPEK. de (BMV:ALPEKA) A Risky Investment?

Feb 23

Is It Too Late To Consider Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Jan 07

Estimating The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)

Dec 22

At Mex$26.92, Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Worth Looking At Closely?

Sep 24

We Think ALPEK. de (BMV:ALPEKA) Can Stay On Top Of Its Debt

Aug 30

Should You Think About Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Now?

Jun 18

Analysts Just Made A Neat Upgrade To Their ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Forecasts

May 28

These 4 Measures Indicate That ALPEK. de (BMV:ALPEKA) Is Using Debt Reasonably Well

May 05

Growth Investors: Industry Analysts Just Upgraded Their ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Revenue Forecasts By 11%

Feb 21

Is ALPEK. de (BMV:ALPEKA) A Risky Investment?

Feb 01

An Intrinsic Calculation For ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Suggests It's 23% Undervalued

Jan 10

Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Potentially Undervalued?

Dec 24

ALPEK. de (BMV:ALPEKA) Seems To Use Debt Quite Sensibly

Oct 26

Desglose de ingresos y gastos

Cómo gana y gasta dinero ALPEK. de. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

BMV:ALPEK A Ingresos, gastos y beneficios (MXN Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Sep 24	132,434	-10,103	5,622
30 Jun 24	128,647	-11,026	5,492
31 Mar 24	131,934	-10,686	5,668
31 Dec 23	138,159	-10,914	5,896
30 Sep 23	156,683	767	6,144
30 Jun 23	183,065	3,453	6,522
31 Mar 23	203,133	8,955	6,846
31 Dec 22	212,435	13,744	6,959
30 Sep 22	208,689	13,602	7,364
30 Jun 22	190,591	13,576	7,042
31 Mar 22	171,271	10,001	6,499
31 Dec 21	156,224	7,756	6,095
30 Sep 21	140,268	9,175	5,673
30 Jun 21	127,927	8,392	5,429
31 Mar 21	118,297	6,028	5,438
31 Dec 20	113,989	3,123	5,440
30 Sep 20	112,413	5,151	5,313
30 Jun 20	112,662	4,691	5,176
31 Mar 20	116,640	5,635	5,083
31 Dec 19	119,685	6,605	4,961
30 Sep 19	127,354	10,373	5,110
30 Jun 19	134,627	10,913	5,221
31 Mar 19	137,345	12,601	5,384
31 Dec 18	134,523	13,633	5,323
30 Sep 18	124,731	5,240	6,892
30 Jun 18	111,272	-3,406	6,467
31 Mar 18	101,404	-5,707	6,022
31 Dec 17	98,998	-5,487	5,884
30 Sep 17	97,416	-4,366	3,807
30 Jun 17	97,173	3,697	3,831
31 Mar 17	95,240	4,112	3,775
31 Dec 16	90,192	3,625	3,665
30 Sep 16	87,174	3,558	3,630
30 Jun 16	86,103	3,248	3,526
31 Mar 16	85,161	3,654	3,434
31 Dec 15	83,590	2,748	3,247
30 Sep 15	85,981	1,844	3,046
30 Jun 15	85,331	1,615	2,866
31 Mar 15	84,935	860	2,678
31 Dec 14	86,072	801	2,565
30 Sep 14	84,225	1,105	2,411
30 Jun 14	86,022	1,248	2,351
31 Mar 14	87,636	-198	2,292
31 Dec 13	90,061	262	2,210

Ingresos de calidad: ALPEK A actualmente no es rentable.

Margen de beneficios creciente: ALPEK A actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: ALPEK A no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 36.8% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ALPEK A en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: ALPEK A no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (-6.6%).

Rentabilidad financiera

Alta ROE: ALPEK A tiene una rentabilidad financiera negativa (-26.79%), ya que actualmente no es rentable.

ALPEK. de Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ALPEK, S.A.B. de C.V. to Report Q3, 2024 Results on Oct 28, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

ALPEK, S.A.B. de C.V. to Report Q2, 2024 Results on Jul 24, 2024

First quarter 2024 earnings released: EPS: Mex$0.065 (vs Mex$0.043 loss in 1Q 2023)

ALPEK, S.A.B. de C.V. to Report Q1, 2024 Results on Apr 23, 2024

Recent updates

New minor risk - Share price stability

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ALPEK, S.A.B. de C.V. to Report Q3, 2024 Results on Oct 28, 2024

Why We're Not Concerned About ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Share Price

Returns On Capital Signal Difficult Times Ahead For ALPEK. de (BMV:ALPEKA)

Should You Investigate ALPEK, S.A.B. de C.V. (BMV:ALPEKA) At Mex$11.86?

ALPEK, S.A.B. de C.V. Just Missed Earnings - But Analysts Have Updated Their Models

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

ALPEK, S.A.B. de C.V. to Report Q2, 2024 Results on Jul 24, 2024

A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)

Some Investors May Be Worried About ALPEK. de's (BMV:ALPEKA) Returns On Capital

Now 21% overvalued after recent price rise

Earnings Miss: ALPEK, S.A.B. de C.V. Missed EPS By 51% And Analysts Are Revising Their Forecasts

First quarter 2024 earnings released: EPS: Mex$0.065 (vs Mex$0.043 loss in 1Q 2023)

What ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) P/S Is Not Telling You

ALPEK, S.A.B. de C.V. to Report Q1, 2024 Results on Apr 23, 2024

Now 20% overvalued after recent price rise

At Mex$12.61, Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Worth Looking At Closely?

ALPEK. de (BMV:ALPEKA) Has A Somewhat Strained Balance Sheet

New major risk - Financial position

ALPEK, S.A.B. de C.V., Annual General Meeting, Mar 06, 2024

ALPEK, S.A.B. de C.V. to Report Q4, 2023 Results on Feb 20, 2024

A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)

Investor Optimism Abounds ALPEK, S.A.B. de C.V. (BMV:ALPEKA) But Growth Is Lacking

Is There Now An Opportunity In ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Consensus EPS estimates fall by 13%

ALPEK. de (BMV:ALPEKA) Use Of Debt Could Be Considered Risky

Consensus EPS estimates fall by 20%

Consensus EPS estimates fall by 50%

Investor sentiment deteriorates as stock falls 27%

New minor risk - Share price stability

Price target decreased by 7.6% to Mex$23.53

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

ALPEK, S.A.B. de C.V. to Report Q3, 2023 Results on Oct 23, 2023

Consensus EPS estimates fall by 11%

Is Now The Time To Look At Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

New minor risk - Profit margin trend

Consensus EPS estimates fall by 10%

Price target decreased by 8.0% to Mex$26.44

Consensus EPS estimates increase by 13%, revenue downgraded

Second quarter 2023 earnings released

ALPEK. de (BMV:ALPEKA) Has A Somewhat Strained Balance Sheet

ALPEK, S.A.B. de C.V. to Report Q2, 2023 Results on Jul 26, 2023

ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Intrinsic Value Is Potentially 91% Above Its Share Price

Consensus EPS estimates fall by 11%

The ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Analysts Have Been Trimming Their Sales Forecasts

First quarter 2023 earnings: EPS and revenues miss analyst expectations

When Should You Buy ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Consensus EPS estimates fall by 13%

An Intrinsic Calculation For ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Suggests It's 34% Undervalued

These Analysts Think ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Sales Are Under Threat

Consensus revenue estimates fall by 10%

Is ALPEK. de (BMV:ALPEKA) A Risky Investment?

Now 23% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 15%

ALPEK, S.A.B. de C.V. to Report Q4, 2022 Results on Feb 15, 2023

Is It Too Late To Consider Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?

Estimating The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)

Insufficient new directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

ALPEK, S.A.B. de C.V. to Report Q3, 2022 Results on Oct 20, 2022

At Mex$26.92, Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Worth Looking At Closely?

We Think ALPEK. de (BMV:ALPEKA) Can Stay On Top Of Its Debt

Now 21% undervalued after recent price drop

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates increase by 12%

ALPEK, S.A.B. de C.V. to Report Q2, 2022 Results on Jul 20, 2022

Should You Think About Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Now?